Granules India Limited (BSE: 532482)
Health Care · Pharmaceuticals · IN
Rs813.85
-0.85% today · +43.7% 1Y
Granules India Limited (BSE: 532482) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.08B.
Over the last twelve months the share price has gained 43.7%, trading between 520.05 and 922.10.
Tweenvest scores Granules India Limited across four factors: quality 73/100, value 20/100, growth 55/100, dividend 42/100. Its strongest factor is quality.
532482 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.08B
- Revenue (TTM)
- $595.69M
- P/E
- 30.20
- EPS
- 26.95
- Dividend yield
- 0.21%
- Beta (5Y)
- 0.12
- 52-week high
- Rs922.10
- 52-week low
- Rs520.05
- Avg volume (3M)
- —
- Shares outstanding
- 247.80M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Dermapharm Holding SEXTRA: DMP | $2.13B | €38.30 | -0.26% |
| Grand Pharmaceutical Group LimitedSEHK: 512 | $2.12B | HK$4.74 | -1.76% |
| Zhejiang Jiuzhou Pharmaceutical Co., LtdSHSE: 603456 | $2.09B | CN¥16.31 | -2.63% |
| Perrigo Company plcNYSE: PRGO | $2.09B | $15.41 | +2.32% |
| Zhejiang Hisun Pharmaceutical Co., Ltd.SHSE: 600267 | $2.06B | CN¥11.94 | +1.62% |
| Shilpa Medicare LimitedBSE: 530549 | $2.06B | Rs1,020.35 | -4.07% |
| Trulieve Cannabis Corp.NYSE: TRLV | $2.05B | $10.67 | +2.89% |
| Fujian Cosunter Pharmaceutical Co., Ltd.SZSE: 300436 | $2.04B | CN¥81.47 | -2.64% |
Figures last refreshed Oct 11, 2026.